Literature DB >> 31049247

A Retrospective Study of Cochlear Re-Implantations - Experience from a Large Centre in India.

Abha Kumari1, Sunil Goyal2, Senthil Vadivu Arumugam3, Viswanathan Vasumathi3, Neha Chauhan3, Mohan Kameswaran3.   

Abstract

OBJECTIVE: Cochlear re-implantation (CRI) is becoming increasingly common throughout the world. However, studies regarding CRI incidence and etiology are lacking from developing countries like ours. The aim of this study was to present the Indian experience with CRI based on our experience. Objectives were to determine the incidence and the indications of CRI and the cumulative survival rate (CSR) of cochlear implantation (CI).
METHODS: Our study was a retrospective one, conducted at a tertiary care centre in southern India. 1,500 consecutive cochlear implanted ears from 1997 to 2016 were studied. All patients who underwent CRI during this period were included in the study.
RESULTS: There were a total of 53 ears (31 male and 22 female ears) who underwent CRI. This gives an incidence of 3.53%. The most common indication of CRI was device failure in 39 ears contributing to 73.6% of the total CRI. The overall CSR of CI in pediatric population was 96.5% over a 20-year period.
CONCLUSION: The CRI incidence and etiology at our centre appears to reflect the findings of the literature. Cochlear implant centres across the world should report the CSR of devices used at their respective centres so that it can be made an important criterion in choice of implant.

Entities:  

Keywords:  Cochlear implantation; cumulative survival rate; developing countries; device failure

Year:  2019        PMID: 31049247      PMCID: PMC6461329          DOI: 10.5152/tao.2019.3976

Source DB:  PubMed          Journal:  Turk Arch Otorhinolaryngol        ISSN: 2667-7466


  16 in total

Review 1.  Cochlear implant failure: imaging evaluation of the electrode course.

Authors:  R Jain; S K Mukherji
Journal:  Clin Radiol       Date:  2003-04       Impact factor: 2.350

2.  Incidence and indications for revision cochlear implant surgery in adults and children.

Authors:  Kevin D Brown; Sarah S Connell; Thomas J Balkany; Adrien E Eshraghi; Fred F Telischi; Simon A Angeli
Journal:  Laryngoscope       Date:  2009-01       Impact factor: 3.325

3.  Intraoperative neural response telemetry as a predictor of performance.

Authors:  Maura K Cosetti; William H Shapiro; Janet E Green; Benjamin R Roman; Anil K Lalwani; Stacey H Gunn; John Thomas Roland; Susan B Waltzman
Journal:  Otol Neurotol       Date:  2010-09       Impact factor: 2.311

4.  Revision cochlear implant surgery in children: the Johns Hopkins experience.

Authors:  Andrea L Marlowe; Jill E Chinnici; Alejandro Rivas; John K Niparko; Howard W Francis
Journal:  Otol Neurotol       Date:  2010-01       Impact factor: 2.311

5.  Cochlear implant failures and revision.

Authors:  Amy-Anne Donatelli Lassig; Teresa A Zwolan; Steven A Telian
Journal:  Otol Neurotol       Date:  2005-07       Impact factor: 2.311

6.  Reliability of cochlear implants.

Authors:  Jan Maurer; Nicolaos Marangos; E Ziegler
Journal:  Otolaryngol Head Neck Surg       Date:  2005-05       Impact factor: 3.497

7.  Analysis of fifty-six cochlear implant device failures.

Authors:  Jan Gosepath; Karl Lippert; Annerose Keilmann; Wolf J Mann
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2009-04-16       Impact factor: 1.538

8.  Revision cochlear implant surgery in children.

Authors:  Robert D Cullen; Jose N Fayad; William M Luxford; Craig A Buchman
Journal:  Otol Neurotol       Date:  2008-02       Impact factor: 2.311

9.  Cochlear reimplantation: causes of failure, outcomes, and audiologic performance.

Authors:  Mathieu Côté; Pierre Ferron; François Bergeron; Richard Bussières
Journal:  Laryngoscope       Date:  2007-07       Impact factor: 3.325

10.  Clinical outcomes of cochlear reimplantation due to device failure.

Authors:  Chong-Sun Kim; Dong-Kyu Kim; Myung-Whan Suh; Seung Ha Oh; Sun O Chang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-03-20       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.